RxDoctor Payments Data

Malinda Linn, DO

Family Medicine · Hendersonville, TNNPI 1487778635

Payments from drug & device makers

$14,468in general payments, 2019–2025

Across 73 payments — averaging $198.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optos, Inc.$10K
  • Teva Pharmaceuticals USA, Inc.$4K
  • Lilly USA, LLC$196
  • Astellas Pharma US Inc$195
  • AbbVie$129
  • AstraZeneca$95
  • plus $478 from 17 others

What the payments were for

  • Consulting fees$2,76119%
  • Speaking & faculty fees$9,57766%
  • Travel & lodging$5564%
  • Food & beverage$1,38010%
  • Education$1951%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,468 in reported general payments places this provider in the 95th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$37,163
Medicare patients
90
Services billed
626

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide57$63,078
EliquisApixaban36$35,970
KerendiaFinerenone24$29,162
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl525$23,247
Bydureon BciseExenatide Microspheres17$19,256
MounjaroTirzepatide14$14,234
JardianceEmpagliflozin15$13,971
Breo ElliptaFluticasone/Vilanterol26$12,663
JanuviaSitagliptin Phosphate19$10,674
GemtesaVibegron11$5,104
Atorvastatin Calcium318$3,447
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$3,322
SynthroidLevothyroxine Sodium41$3,003
Levothyroxine Sodium204$2,379
Gabapentin74$2,252

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$20$63,07857 claims
PfizerEliquis$30$35,97036 claims
BayerKerendia$34$29,16224 claims
Lilly USA, LLCMounjaro$196$14,23414 claims
Sumitomo Pharma America, Inc.Gemtesa$39$5,10411 claims
AbbVieSynthroid$129$3,00341 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Hendersonville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →